文献速递认知障碍与痴呆

类风湿关节炎与痴呆患者认知障碍进展及死亡风险的关联

Association of Rheumatoid Arthritis With Progression of Cognitive Impairment and Risk of Mortality in People With Dementia.
PubMed 文献 · Neurology · 2025-02-07

基于瑞典SveDem登记库的倾向评分匹配队列研究,纳入1685例合并类风湿关节炎(RA)的痴呆患者与5055例非RA痴呆患者。中位随访2.6-2.9年,RA组认知下降更快(β=-0.24分/年,95%CI -0.38至-0.10),全因死亡风险升高(HR 1.15,95%CI 1.06-1.24)。

要点

  • 合并RA的痴呆患者认知下降速度较非RA患者更快,β=-0.24分/年(95%CI -0.38至-0.10)。
  • 合并RA的痴呆患者全因死亡风险较非RA患者升高,HR 1.15(95%CI 1.06-1.24)。
  • 基线MMSE评分与居住条件对RA与认知下降的关联存在显著交互作用(交互P<0.05)。

核心结论

  • 合并类风湿关节炎的痴呆患者较非RA痴呆患者认知功能更差且死亡风险升高。

研究设计与样本

  • 基于瑞典认知/痴呆疾病登记库(SveDem)的倾向评分匹配登记库队列研究。
  • 纳入2007年5月1日至2018年10月16日登记于SveDem的痴呆患者,包括1685例合并RA者与5055例非RA者。
  • 合并RA者平均(SD)年龄79.9(6.7)岁,女性占73.4%;非RA者平均(SD)年龄80.1(7.5)岁,女性占73.1%。
  • 非RA组中位随访2.9年(四分位距1.5-4.6年),RA组中位随访2.6年(四分位距1.4-4.2年)。
  • 采用混合效应模型分析RA与认知下降的关联,Cox比例风险模型分析全因死亡风险,并进行亚组分析。

主要发现

  • 共分析111266次MMSE测量值。
  • 与非RA患者相比,RA患者认知下降更快(β=-0.24分/年;95%CI -0.38至-0.10)。
  • 与非RA患者相比,RA患者死亡风险升高(HR 1.15;95%CI 1.06-1.24)。
  • 亚组分析中,RA与基线MMSE评分及居住条件对认知下降存在显著交互作用(交互P<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 缺乏痴呆发病前RA病程及疾病活动度的信息,可能影响研究结果。
  • 需进一步研究在可比人群中验证这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Rheumatoid arthritis (RA) has been linked to an increased risk of dementia, yet little is known about how RA affects the progression of cognitive impairment and the risk of mortality in people with dementia. We aimed to investigate whether RA is linked to an accelerated cognitive decline and a higher risk of all-cause mortality in patients with dementia. METHODS: We conducted a propensity score-matched register-based cohort study based on the Swedish Registry for Cognitive/Dementia Disorders-SveDem. Patients diagnosed with dementia and registered in SveDem between May 1, 2007, and October 16, 2018, were included. The main outcome for the study was cognitive decline, measured by Mini-Mental State Examination (MMSE) score changes over years. The secondary outcome was all-cause death. We used mixed-effects models to examine the association between RA and cognitive decline, and Cox proportional hazards models to investigate the risk of all-cause mortality. We also conducted subgroup analyses to explore the potential effects of sociodemographic, baseline MMSE, comorbidities, and the use of dementia medications on the association between RA and outcomes. RESULTS: We included 1,685 dementia patients with RA (mean [SD] age, 79.9 [6.7] years; 73.4% were women) and 5,055 dementia patients with non-RA (80.1 [7.5] years; 73.1% were women). The median follow-up was 2.9 years (interquartile range, 1.5-4.6 years) for non-RA and 2.6 years (interquartile range, 1.4-4.2 years) for RA. In total, 111,266 MMSE measurements were available for analysis. Compared with non-RA patients, patients with RA presented faster cognitive decline (β = -0.24 points/y; 95% CI -0.38 to -0.10) and an increased risk of death (hazard ratio 1.15; 95% CI 1.06-1.24). In subgroup analysis, significant interactions were observed between RA and baseline MMSE scores as well as living conditions regarding cognitive decline (p for interaction <0.05). DISCUSSION: We identified a worse cognitive function and an increased mortality risk in dementia patients with RA compared with non-RA. However, we lacked information on the duration of RA before the onset of dementia and on disease activity, which could influence our findings. Further studies are needed to validate these results in comparable populations.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mo M, Eriksdotter M, Ajeganova S, et al. Association of Rheumatoid Arthritis With Progression of Cognitive Impairment and Risk of Mortality in People With Dementia. Neurology. 2025. PMID: 39919256. doi:10.1212/WNL.0000000000213405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。